BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32427557)

  • 1. Cancer Yield and Patterns of Follow-up for BI-RADS Category 3 after Screening Mammography Recall in the National Mammography Database.
    Berg WA; Berg JM; Sickles EA; Burnside ES; Zuley ML; Rosenberg RD; Lee CS
    Radiology; 2020 Jul; 296(1):32-41. PubMed ID: 32427557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Yield Exceeds 2% for BI-RADS 3 Probably Benign Findings in Women Older Than 60 Years in the National Mammography Database.
    Lee CS; Berg JM; Berg WA
    Radiology; 2021 Jun; 299(3):550-558. PubMed ID: 33787333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial.
    Barr RG; Zhang Z; Cormack JB; Mendelson EB; Berg WA
    Radiology; 2013 Dec; 269(3):701-12. PubMed ID: 23962417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization and Cancer Yield of Probably Benign Assessment Category in the National Mammography Database: 2009 to 2018.
    Elezaby MA; Mao L; Burnside ES; Zuley ML; Berg WA; Bhargavan-Chatfield M; Lee CS
    J Am Coll Radiol; 2022 May; 19(5):604-614. PubMed ID: 35358482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why Start Now? Retrospective Study Evaluating Baseline Screening Mammography in Patients Age 60 and Older.
    Chieh AY; Willis JG; Carroll CM; Mobley AA; Li Y; Li M; Woodard S
    Curr Probl Diagn Radiol; 2024; 53(1):62-67. PubMed ID: 37704485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Single-Center Audit of BI-RADS 3 Assessment Category Utilization in Mammography and Breast Ultrasound.
    Common J; Abdullah P; Alabousi A
    Can Assoc Radiol J; 2023 Feb; 74(1):69-77. PubMed ID: 36041944
    [No Abstract]   [Full Text] [Related]  

  • 7. ACR BI-RADS Assessment Category 4 Subdivisions in Diagnostic Mammography: Utilization and Outcomes in the National Mammography Database.
    Elezaby M; Li G; Bhargavan-Chatfield M; Burnside ES; DeMartini WB
    Radiology; 2018 May; 287(2):416-422. PubMed ID: 29315061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.
    Yao MM; Joe BN; Sickles EA; Lee CS
    Acad Radiol; 2019 Aug; 26(8):1048-1052. PubMed ID: 30195413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient compliance and diagnostic yield of 18-month unilateral follow-up in surveillance of probably benign mammographic lesions.
    Chung CS; Giess CS; Gombos EC; Frost EP; Yeh ED; Raza S; Birdwell RL
    AJR Am J Roentgenol; 2014 Apr; 202(4):922-7. PubMed ID: 24660725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.
    Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
    AJR Am J Roentgenol; 2016 Mar; 206(3):666-72. PubMed ID: 26901026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of BI-RADS 3-probably benign category in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening Trial.
    Baum JK; Hanna LG; Acharyya S; Mahoney MC; Conant EF; Bassett LW; Pisano ED
    Radiology; 2011 Jul; 260(1):61-7. PubMed ID: 21502382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
    Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
    Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the mammographic follow-up of BI-RADS category 3 lesions.
    Varas X; Leborgne JH; Leborgne F; Mezzera J; Jaumandreu S; Leborgne F
    AJR Am J Roentgenol; 2002 Sep; 179(3):691-5. PubMed ID: 12185047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.
    Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE
    Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growing BI-RADS category 3 lesions on follow-up breast ultrasound: malignancy rates and worrisome features.
    Ha SM; Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
    Br J Radiol; 2018 Jul; 91(1087):20170787. PubMed ID: 29658793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and Outcomes of BI-RADS Category 3 Assessments in Patients With a Personal History of Breast Cancer: Full-Field Digital Mammography Versus Digital Breast Tomosynthesis.
    Offit LR; Chikarmane SA; Lacson RC; Giess CS
    AJR Am J Roentgenol; 2023 Sep; 221(3):313-322. PubMed ID: 37095672
    [No Abstract]   [Full Text] [Related]  

  • 17. BI-RADS Category 3 Comparison: Probably Benign Category after Recall from Screening before and after Implementation of Digital Breast Tomosynthesis.
    McDonald ES; McCarthy AM; Weinstein SP; Schnall MD; Conant EF
    Radiology; 2017 Dec; 285(3):778-787. PubMed ID: 28715278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Return to Routine Screening for BI-RADS 3 Lesions Detected at Supplemental Automated Whole-Breast Ultrasound in Women With Dense Breasts: A Prospective Study.
    Barr RG; DeSivestri A; Golatta M
    AJR Am J Roentgenol; 2021 Dec; 217(6):1313-1321. PubMed ID: 34259039
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
    Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
    Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.